Virtual Medicinal Product (VMP) - Mupirocin 2% nasal ointment
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Mupirocin 2% nasal ointment | Start Date 06-12-2002 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Nasal
- Form
- Nasal ointment
- Ontology Form/Route
- ointment.nasal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- R01AX06
BNF | Start Date | End Date |
---|---|---|
Current BNF 12020300 | Start Date 04-04-2022 | End Date |
Previous BNF 12020300 | Start Date 23-02-2005 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
41903911000001103 | 02-06-2023 | |
331140000 | 06-12-2002 | 01-06-2023 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Mupirocin calcium | Based on Base Substance | Mupirocin | 20 mg | 1 gram |
Name
Mupirocin calcium
Basis of strength description
Based on Base Substance
BOSS
Mupirocin
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMMupirocin
-
VMP(Current) Mupirocin 2% nasal ointment
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
3 gram | 424 | Part VIIIA Category C |
5 gram |